PeptidePedia The community reference

Contributions of DataTableDunja

User contributions·28 logged edits·page 1 of 1

Contributions by DataTableDunja, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 422 edits includes activity predating the current log.

  1. 09:21, 21 Jun 2026 (diff | hist) Exenatide 5,754 ±0 m give the INN alongside the trade name at first mention
  2. 11:30, 14 Jun 2026 (diff | hist) Talk:PeptideMeter 674 +151 /* Small-sample rankings */ new section
  3. 14:50, 10 Jun 2026 (diff | hist) Talk:STEP trial programme 885 +143 /* The mean describes nobody */ reply
  4. 15:33, 14 May 2026 (diff | hist) Talk:GLP-1 receptor 674 +144 /* Heart-rate figure */ new section
  5. 17:18, 8 May 2026 (diff | hist) Number needed to treat 4,718 ±0 the trial was open-label; the article implied blinding
  6. 12:36, 27 Apr 2026 (diff | hist) Gastric emptying 5,565 ±0 add the enteroendocrine cell type responsible for secretion
  7. 10:20, 27 Apr 2026 (diff | hist) Talk:Intention-to-treat analysis 537 +146 /* Which estimand a source used */ new section
  8. 15:29, 18 Apr 2026 (diff | hist) Reverse-phase HPLC 5,499 ±0 convert the method-comparison paragraph to a table
  9. 15:18, 22 Nov 2025 (diff | hist) Sangon Biotech 14,544 +1,120 add the note that this wiki publishes no score and no league table
  10. 02:08, 4 Nov 2025 (diff | hist) SURPASS trial programme 5,078 ±0 add the number randomised and the number completing
  11. 16:51, 22 Oct 2025 (diff | hist) TRIUMPH trial programme 4,703 ±0 cite the trial publication rather than the sponsor press release
  12. 13:26, 4 Oct 2025 (diff | hist) SELECT trial 5,171 ±0 add the missing-data handling method
  13. 12:45, 10 Aug 2025 (diff | hist) SELECT trial 5,171 +320 m rm the cross-trial comparison; the populations are not comparable
  14. 19:48, 31 Jul 2025 (diff | hist) Area percent purity 7,380 ±0 m expand §What area percent cannot see
  15. 15:29, 24 Jun 2025 (diff | hist) Talk:Trial data comparison 748 +329 /* Should the bars be there at all? */ reply
  16. 10:50, 15 Jun 2025 (diff | hist) SELECT trial 4,851 ±0 m add the trial acronym expansion at first use
  17. 20:03, 12 Jun 2025 (diff | hist) Baseline laboratory panel 4,222 ±0 m expand §Common components
  18. 01:24, 19 May 2025 (diff | hist) Dipeptidyl peptidase-4 6,022 ±0 add the enteroendocrine cell type responsible for secretion
  19. 22:12, 30 Apr 2025 (diff | hist) Loss on drying 3,765 +30 move a stray full stop inside the reference
  20. 11:19, 19 Jan 2025 (diff | hist) Number needed to treat 3,241 +34 rm the cross-trial comparison; the populations are not comparable
  21. 17:13, 4 Jan 2025 (diff | hist) SURPASS trial programme 3,774 ±0 name the funder in the sentence, per PP:MOS
  22. 04:23, 21 Sep 2024 (diff | hist) TRIUMPH trial programme 1,217 ±0 rm the cross-trial comparison; the populations are not comparable
  23. 09:09, 29 Aug 2024 (diff | hist) STEP trial programme 3,212 ±0 give the absolute risk difference alongside the relative one
  24. 10:56, 14 Aug 2024 (diff | hist) STEP trial programme 3,212 +353 m give the primary endpoint as pre-specified, not as reported
  25. 15:34, 9 Aug 2024 (diff | hist) SELECT trial 1,189 ±0 m add the number randomised and the number completing
  26. 18:28, 2 Aug 2024 (diff | hist) SURMOUNT trial programme 2,057 +943 add the confidence interval to the point estimate
  27. 09:00, 21 Jul 2024 (diff | hist) SURPASS trial programme 1,200 +1,200 N start article; endpoints and registration only
  28. 06:33, 13 Jul 2024 (diff | hist) STEP trial programme 2,343 ±0 add the missing-data handling method